Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

FLUENZ SUSPENSION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/FLUENZ SUSPENSION PARA PULVERIZACION NASAL

Approved

STANDARD

FLUENZ SUSPENSION PARA PULVERIZACION NASAL

Astrazeneca Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 11, 2024
Approval ID: 0ac761aab4fa0afc
Company: Astrazeneca Ab
Type: Standard

Approval Details

Approval Id: 0ac761aab4fa0afc
Drug Cima Aemps Name: FLUENZ SUSPENSION PARA PULVERIZACION NASAL
Register Number: 1241816001
Holder Company Name: Astrazeneca Ab
Marketing Company Name: Astrazeneca Farmaceutica Spain S.A.
Holder Company Detail Path: /organization/astrazeneca-ab
Authorization Date: 2024-06-11
Dosage Form: SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose: 7 ± 0,5 log10
Route Of Administration: VÍA NASAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Astrazeneca Ab
Company Detail Path: /organization/astrazeneca-ab

Company Information

Pharmaceutical Company Name: ASTRAZENECA AB
Country Name: Spain
City Name: madrid,madrid,country_es
Address: CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website: http://www.astrazeneca.se

Active Ingredients

VIRUS INFLUENZA GRIPE, VIVO ATENUADO,REASORTANTE CEPA SIMILAR A A/ VICTORIA/4897/2022 (H1N1) PDM09

7,0 ± 0,5 FFU

VIRUS INFLUENZA GRIPE A/THAILAND/8/2022 (H3N2) IVR-237 CEPA SIMILAR A (A/THAILAND/8/2022)

7,0 ± 0,5 FFU

VIRUS INFLUENZA GRIPE REASORTANTE,VIVO, ATENUADO, CEPA SIMILAR A B/ AUSTRIA/1359417/2021

7,0 ± 0,5 FFU

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 11, 2024

Approval ID

0ac761aab4fa0afc

Type

Standard

Back to CIMA-AEMPS Approvals